I put our editorial in NotebookLM and it made a video podcast! I cant post it though because its more than 3 minutes. #APLAR25
This is the favorite platform of our participants in our AI workshops
I realized I haven't posted this yet: our #APLAR25 Social Media report pubmed.ncbi.nlm.nih.gov/41192345/
In case you missed it, the APLAR AYR Social Media committee interviewed key speakers during the #APLAR25 conference. please watch, share, and comment on the full reels at the instagram account. (@ aplar_ayr) www.instagram.com/s/aGlnaGxpZ2...
rheumnow.com/news/aplar-2...
πAPLAR 2025: Whatβs New in RA Management?
#RA #rheumatoidarthritis #aplar25
#APLAR
@rheumnow.bsky.social
Day3 #aplar25 recapπ·
Plenary3
βHuman #SLEβ Prof V.Pascual
πTh10=CXCL13-IL10+IL21+CXCR3+PD1+(contains CD38high) and Tph=CXCL13+IL10-IL21+ are both expanded in SLEπ©Έ
π Unique Transcriptional Features of NaΓ―ve SLE Treg: FCRL3βTLR5β
β¦TLR5 Ligation decreasesβ¬οΈ SLE Naive Treg Suppressive Function
#lupus
Fresh off the printer! #APLAR25 pdf.sciencedirectassets.com/788981/AIP/1...
My #APLAR25 Special Interest Group is on Digital Health and Telemedicine (and AI!) if you're a rheum/immuno/ortho with the same interest, drop by our session at Rm 411&412! π€
#APLAR25 SLE organ damage: d/t dse or d/t treatment
2οΈβ£Prof Ellen
βThe changing landscape of #RA β
#arthritis
πRA begins years before synovitis, with loss of tolerance and autoAbβ.
πPrevention trials delay(not prevent) disease onset.
π Cell types in synovial tissue differ from bloodβ¦Can synovial tissue be used as a predictor of Tx response?
#aplar25
Day1 #APLAR25
Plenary1
1οΈβ£Prof Josef Smolen
βManaging #RA in
2025: Update of #EULAR
recommendationsβ
π Many recommendations of the 2022 remain unchanged.
π JAKi continue to be recommended for pts without risk factors, but otherwise same level (phase Il) as bDMARDs
#arthritis #AYR
#APLAR25 in an aging world population, chronic diseases differ in manifestation: Elderly onset vs Young/Lifelong onset
#APLAR25 Prof Smolen with RA updates. Maaring kaya sa isa kong hospital pero sa kabila kong hospital hirap tlga ako mag convince dahil sa costs. Di naman daw mali, basta stick to 3 months monitoring
From the AURORA study:
Exposure to voclosporin was not associated with nephrotoxicity on repeat kidney biopsy after 18 months.
However, monitor for hypertension and CNI-related nephropathy as potential side effects.
#lupus #lupusnephritis
#APLAR25 π¦π«
Just got to #APLAR25β£οΈ
Attending βUpdates and Case Studies in #SLEβ session π¦
Opening ceremony coming up in a few hours!
#APLAR25 #lupus #AYR
#APLAR25
Tech based Patient Education ideas:
#APLAR25
Patient Education
#APLAR25
elements of Patient Education:
- socioculturaleconomic resources
- medium (md-pt, pt-pt)
- design
#APLAR25 Motivational Interview tips:
π£οΈπ£οΈπ£οΈπ£οΈ
....thats a valid worry....
....would it help if we discuss the side effects?...
....how does that sound to you (acceptable monitoring)
....can you repeat back?
....so you can do (prior activity again)
#APLAR25 do patients have enought mental health support? π₯²πβ€οΈβπ©Ή
#APLAR25
1:1 patient education strategies
π£οΈ ask-tell-ask
π£οΈ teach-back (repetition)
π£οΈ pharmacist & nurse roles β€οΈ
π£οΈ assess need: survey
barriers: β° TIME, communication training π«
#APLAR25
AI & patient educ: simplification of medical jargon
βΌοΈ caution for emission or oversimplication (md must monitor!)
www.rheumatologyadvisor.com/features/use...
#APLAR25
Patients want to be educated! (would be interesting to see if this still same % in the era of social media & misinformation)
- at dx
- at changes in rx
- when required by pts psychological status
#APLAR25
"its not to get rid of stress
its to handle stress in a healthy manner"
-atntanveer
#quotablequotes
#APLAR25 Patient Education: πwords: INTERACT, ENABLE
π patients are active agents in managing illness & healthcare
π SHARED decision making
#APLAR25 Workshops:
Minimally invasive MSG biopsy
vimeo.com/chuv/review/...
Iβm happy to share that Iβll give an oral presentation on Day 1 (Sept 6) at Abstract Session 1: Mechanism of Rheumatic Disease, on our latest work on #Sjogrens disease.
Iβm also excited to co-host the #AYR Quiz with friends this year!
Join us and test your rheum knowledge β prizes await! π
#APLAR25
β³ Counting down to #APLAR25
Just arrived in #Fukuoka for tomorrowβs Opening Ceremonyβ£οΈ
Iβll be sharing what I learn and experience here π
Please also check the official #AYR accounts on Instagram & LinkedIn tooβοΈ
Letβs learn, connect & grow together β€οΈ
#Rheumsky #APLAR
@rheumarhyme.bsky.social